---
title: "Moderna 股票上涨 15%，多头因药物研发管线更新而欢呼：下一目标是 75 美元？"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/290996249.md"
description: "Moderna 的股价在其药物研发的积极商业更新后上涨了近 15%，达到约 69 美元，包括在癌症和自身免疫治疗方面的进展。过去一个月，该股上涨了约 42%，表现优于标准普尔 500 指数。技术指标显示，如果突破 68 美元的阻力位，可能会向 75 美元上涨，支撑位在 63 美元。尽管股价上涨，分析师仍维持持有评级"
datetime: "2026-06-26T18:05:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290996249.md)
  - [en](https://longbridge.com/en/news/290996249.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290996249.md)
---

# Moderna 股票上涨 15%，多头因药物研发管线更新而欢呼：下一目标是 75 美元？

Moderna (MRNA) shares surged nearly ~15% on Friday to around ~$69 and are now up almost ~42% over the past month. The stock has also crushed the S&P 500 (SP500)'s return of ~7.49%, delivering gains of more than ~114% over the same period. The Moderna stock rally came after the company shared a major business update on its Science Day event that gav...

### 相关股票

- [MRNA.US](https://longbridge.com/zh-CN/quote/MRNA.US.md)
- [MRNX.US](https://longbridge.com/zh-CN/quote/MRNX.US.md)
- [MRNY.US](https://longbridge.com/zh-CN/quote/MRNY.US.md)
- [.SPX.US](https://longbridge.com/zh-CN/quote/.SPX.US.md)

## 相关资讯与研究

- [9:0 全票过审，Moderna mRNA 流感疫苗叩响 FDA 大门：双轨审批下的入场券与行业分水岭](https://longbridge.com/zh-CN/news/290422959.md)
- [美股盘中速递：Moderna 涨 15.35%，FDA 流感疫苗获批预期提振](https://longbridge.com/zh-CN/news/290985782.md)
- [和誉-B 附属和誉医药与礼来深化研发合作 共同推进具有全球潜力的新型候选药物](https://longbridge.com/zh-CN/news/290620877.md)
- [岸迈生物更新招股书：创新底色坚实，长期价值清晰可期](https://longbridge.com/zh-CN/news/290764875.md)
- [“合成致死” 二十年，难产的下一个 PARP](https://longbridge.com/zh-CN/news/290776540.md)